Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.
Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.
复制标题
DOI：
10.1111/j.1467-789x.2009.00708.x
复制
发表时间：
2011-01
期刊：
影响因子：
--
通讯作者：
Glick HA
中科院分区：
文献类型：
--
作者：
Tsai AG;Williamson DF;Glick HA
估算超重和肥胖的人均和总体直接医疗费用，并检验研究设计因素的影响。检索PubMed(1968-2009)、EconLit(1969-2009)和Business SourcePremier(1995-2009)的原创性研究。结果被标准化，以计算每个超重者和每个肥胖者的增量成本，并计算全国的总成本。共有33项美国研究符合审查标准。在4项最高质量的研究中，2008年超重的人均直接医疗成本为266美元，肥胖的人均直接医疗成本为1723美元。超重和肥胖加在一起的全国总成本为1139亿美元。影响成本估计的研究设计因素包括：使用国家样本与更多选择的人群；检查年龄组；包括所有医疗成本与肥胖相关成本；以及定义超重和肥胖的BMI分界点。根据全国卫生保健总支出的来源，超重和肥胖加在一起的直接医疗成本约占美国卫生保健支出的5.0%至10%。未来的研究应该包括具有全国代表性的样本，评估所有年龄段的成年人，报告所有的医疗费用，并使用标准的BMI临界值。
To estimate per-person and aggregate direct medical costs of overweight and obesity and to examine the effect of study design factors. PubMed (1968–2009), EconLit (1969–2009), and Business Source Premier (1995–2009) were searched for original studies. Results were standardized to compute the incremental cost per overweight person and per obese person, and to compute the national aggregate cost. A total of 33 U.S. studies met review criteria. Among the 4 highest quality studies, the 2008 per-person direct medical cost of overweight was $266 and of obesity was $1723. The aggregate national cost of overweight and obesity combined was $113.9 billion. Study design factors that affected cost estimate included: use of national samples versus more selected populations; age groups examined; inclusion of all medical costs versus obesity-related costs only; and BMI cutoffs for defining overweight and obesity. Depending on the source of total national health care expenditures used, the direct medical cost of overweight and obesity combined is approximately 5.0% to 10% of U.S. health care spending. Future studies should include nationally representative samples, evaluate adults of all ages, report all medical costs, and use standard BMI cutoffs.